phosphatidylcholines has been researched along with Inflammatory Bowel Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, R; Cui, B; Ji, G; Xu, J | 1 |
| Alam, MM; Marella, A; Shaquiquzzaman, M; Verma, G | 1 |
| Baird, AC; Lawrance, IC; Lloyd, F | 1 |
| Huang, SK; Peters-Golden, M | 1 |
| Gong, J; Gu, L; Guo, Z; Li, J; Li, Y; Shen, X; Sun, J; Zhao, J; Zhu, W; Zuo, L | 1 |
| Borges-Costa, J; Loreto, H; Marques, S; Vasconcelos, P | 1 |
| Boros, M; Erces, D; Ghyczy, M; Kaszaki, J; Kovács, T; Tiszlavicz, L; Tőkés, T; Varga, G; Vécsei, L | 1 |
| Bryant, RE; Hunter, AJ | 1 |
3 review(s) available for phosphatidylcholines and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Exploring the Phosphatidylcholine in Inflammatory Bowel Disease: Potential Mechanisms and Therapeutic Interventions.
Topics: Colitis, Ulcerative; Crohn Disease; Humans; Inflammation; Inflammatory Bowel Diseases; Phosphatidylcholines | 2022 |
Immunoinflammatory responses in gastrointestinal tract injury and recovery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Biogenic Polyamines; Biomarkers; Cyclooxygenase 2 Inhibitors; Gastrointestinal Tract; Humans; Infections; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Intestinal Mucosa; Lipoxins; Neoplasms; Nitric Oxide; Oxidative Stress; Phosphatidylcholines; Probiotics; Prostaglandins; Reactive Oxygen Species; Stomach Neoplasms | 2013 |
Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease.
Topics: Animals; Colitis, Ulcerative; Crohn Disease; Disease Progression; Fatty Acid Synthases; Fatty Acids, Volatile; Humans; Hydrogen Sulfide; Inflammatory Bowel Diseases; Intestinal Mucosa; Phosphatidylcholines; Prebiotics; Probiotics; Proteinase Inhibitory Proteins, Secretory | 2016 |
5 other study(ies) available for phosphatidylcholines and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Prostaglandin E₂ and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function.
Topics: Animals; Biomarkers; Cytokines; Dinoprostone; Disease Models, Animal; Female; Fibrosis; Gene Expression; Humans; Immunoenzyme Techniques; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Myofibroblasts; Phosphatidylcholines; Real-Time Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid | 2015 |
Prostaglandin E₂ and polyenylphosphatidylcholine: stiff competition for the fibrotic complications of inflammatory bowel disease?
Topics: Animals; Dinoprostone; Female; Humans; Inflammatory Bowel Diseases; Myofibroblasts; Phosphatidylcholines | 2015 |
Secondary syphilis mimicking inflammatory bowel disease.
Topics: Adolescent; Cardiolipins; Cholesterol; Diagnosis, Differential; Humans; Inflammatory Bowel Diseases; Male; Penicillin G; Phosphatidylcholines; Syphilis | 2013 |
[Comparative study of novel therapeutic possibilities in animal experimental model of inflammatory bowel disease].
Topics: Administration, Oral; Animals; Biomarkers; Colitis; Disease Models, Animal; Excitatory Amino Acid Antagonists; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Kynurenic Acid; Microcirculation; Microscopy, Confocal; Peroxidase; Phosphatidylcholines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2012 |
Abdominal wall mucormycosis successfully treated with amphotericin and itraconazole.
Topics: Abdominal Muscles; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Inflammatory Bowel Diseases; Itraconazole; Middle Aged; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols; Pyoderma Gangrenosum; Rhizopus | 2002 |